MED SCI MONITOR 润色咨询

MEDICAL SCIENCE MONITOR

出版年份:暂无数据 年文章数:6066 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:14.4% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2193071, encodeId=8f9921930e1ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床研究;科研<br>经验分享:2024-03-12Rejected2024-03-12Review - rejected2024-03-11Awaiting decision2024-03-112nd Scientific Triage Completed2024-03-11In 2nd Scientific triage2024-02-29Review pending2024-02-29Evaluation requests sent to reviewers2024-02-28Scientific triage completed2024-02-28In scientific triage2024-02-28Manuscript accepted for processing2024-02-28Plagiarism check (submission) 1 ready2024-02-28Sent for anti-plagiarism verification2024-02-28Submissions Approved2024-02-27Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Mar 14 01:54:59 CST 2024, time=2024-03-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2192320, encodeId=a44621923203b, content=投稿命中率:95.0<br>偏重的研究方向:临床研究<br>经验分享:2023-10-25 Paid 2023-10-24 Accepted - invoice issued 2023-10-24 1st Post-Rev plagiarism check ready 2023-10-24 Sent for 1st Post-Rev antiplagiarism check 2023-10-24 Ready for Post-Rev antiplagiarism check 2023-10-24 Awaiting decision 2023-10-23 Review 2 pending 2023-10-23 Review 2 requests sent to reviewers 2023-10-21 After authors corrections 2023-10-09 Sent to author(s) for corrections (2 weeks) 2023-10-09 Reconsider after revision 2023-10-09 Awaiting decision 2023-10-09 2nd Scientific Triage Completed 2023-10-09 In 2nd Scientific triage 2023-10-06 Review pending 2023-10-03 Evaluation requests sent to reviewers 2023-09-23 Review pending 2023-08-31 Evaluation requests sent to reviewers 2023-08-29 Scientific triage completed 2023-08-29 In scientific triage 2023-08-29 Manuscript accepted for processing 2023-08-28 Plagiarism check (submission) 1 ready 2023-08-28 Sent for anti-plagiarism verification 2023-08-28 Submissions Approved 2023-08-28 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Sun Mar 10 00:10:47 CST 2024, time=2024-03-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190508, encodeId=970e219050833, content=在线等,急,请问让转投的Clinical Practice Review and Meta-Analysis这是本什么期刊?pubmed和Web of science都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Fri Mar 01 23:06:35 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2170547, encodeId=f97c21e054770, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综合<br>经验分享:从投到接收不到2个月,总的来说挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Nov 23 17:12:17 CST 2023, time=2023-11-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189743, encodeId=19892189e4301, content=审稿速度:6.0<br>经验分享:2024-02-25<br>Rejected - suggested journal transfer<br>Note: suggested_to Clinical Practice Review and Meta-Analysis<br>2024-01-15<br>Awaiting decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=大星猩, createdTime=Tue Feb 27 20:38:13 CST 2024, time=2024-02-27, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2189494, encodeId=5e8d21894944c, content=它让我转投Clinical Practice Review and Meta-Analysis,我搜都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Mon Feb 26 18:11:00 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189661, encodeId=53cc21896616d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:返修后杂志说crossed out text should be removed, blinded files should be uploaded, same applies to the response letter.到底是啥意思啊?有没有大佬知道的啊,着急死了。上传网页之前上传的文件是删不掉的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14388513788, createdName=ms4000000240525001, createdTime=Tue Feb 27 14:04:42 CST 2024, time=2024-02-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=573054, encodeId=d3855e305470, content=2019-06-27 - Sent to author for corrections (post-review verification) <br> Note: Your anti-plagiarism report is ready. Your manuscript has shown some degree of similarity to previously published material. Please reduce the similarity and rewrite your text where indicated. Be sure that all source material is properly cited and listed in the bibliography. You may upload your revised manuscript when ready. You will find the report in "Antiplagiarism Report" Tab in your Authors Account. <br> 2019-06-27 - After 1st post-review antiplagiarism verification <br> 2019-06-27 - Sent for 1st post-review antiplagiarism verification <br> 2019-06-27 - Ready for post-review antiplagiarism verification <br> 2019-06-27 - Awaiting decision <br> 2019-05-31 - Review 2 pending <br> 2019-05-31 - Review 2 requests sent to reviewers <br> 2019-05-08 - After authors corrections <br> 2019-05-01 - Sent to author for corrections (3 weeks) <br> 2019-05-01 - Reconsider after revision <br> 2019-04-30 - Awaiting decision <br> 2019-04-30 - 2nd Scientific Triage Completed <br> 2019-04-30 - In 2nd Scientific triage <br> 2019-04-18 - Review pending <br> 2019-04-18 - Evaluation requests sent to reviewers <br> 2019-04-17 - Unlocked <br> Note: Author uploaded new file. <br> 2019-04-16 - On hold <br> Note: Please provide us with legends for tables. Also, the entire file, containing all figures and tables, but without information about authors, should be uploaded for the review process. <br> 2019-04-15 - After scientific triage <br> 2019-04-14 - In scientific triage <br> 2019-04-14 - Manuscript accepted for processing <br> 2019-04-12 - Manuscript CrossChecked <br> 2019-04-12 - Sent for Plagiarism CrossCheck <br> 2019-04-12 - Submission Approved <br> 2019-04-12 - Incomplete, correction file uploaded <br> 2019-04-12 - Incomplete, waiting for authors reply <br> Note: The details in the message <br> 2019-04-12 - Incomplete, correction file uploaded <br> 2019-04-11 - Incomplete, waiting for authors reply <br> Note: The details in the message <br> 2019-04-11 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BSVB1WwY0QcChXdZibhTw8u2dzBZ0WtAodehibxMzLASJ1QbQd7oS4r1jvLfn5Eic4ID4qAkQTj55EmbFOHhJZ1rQ/132, createdBy=3bf32416063, createdName=912391303_75271680, createdTime=Fri Jun 28 10:47:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588261, encodeId=8b645882610c, content=您最后文章怎么样了?我也是这个状态<span class="quote">李医生 2020-02-24 00:00:00 发表:<br>你好,请问一下我已经到第三个黑框框了,上面显示 in 2nd scientific traige, review pending已经过去了,这代表什么意思,如果可以的话麻烦您能写一下您在投稿到接受之间的具体流程</span>, beContent=李医生 2020-02-24 00:00:00 发表: 你好,请问一下我已经到第三个黑框框了,上面显示 in 2nd scientific traige, review pending已经过去了,这代表什么意思,如果可以的话麻烦您能写一下您在投稿到接受之间的具体流程, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/E8F0816F065B9BD94C3C0E9796895C76/100, createdBy=c5142399843, createdName=CR7, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170968, encodeId=7ee421e0968b0, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:实在太难投了,根本没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bd8583610, createdName=ms8000002106570968, createdTime=Sat Nov 25 21:10:05 CST 2023, time=2023-11-25, status=1, ipAttribution=湖北省)]
    2024-03-14 ms5000000983971375 来自陕西省

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:临床研究;科研
    经验分享:2024-03-12Rejected2024-03-12Review - rejected2024-03-11Awaiting decision2024-03-112nd Scientific Triage Completed2024-03-11In 2nd Scientific triage2024-02-29Review pending2024-02-29Evaluation requests sent to reviewers2024-02-28Scientific triage completed2024-02-28In scientific triage2024-02-28Manuscript accepted for processing2024-02-28Plagiarism check (submission) 1 ready2024-02-28Sent for anti-plagiarism verification2024-02-28Submissions Approved2024-02-27Submission Received

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2193071, encodeId=8f9921930e1ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床研究;科研<br>经验分享:2024-03-12Rejected2024-03-12Review - rejected2024-03-11Awaiting decision2024-03-112nd Scientific Triage Completed2024-03-11In 2nd Scientific triage2024-02-29Review pending2024-02-29Evaluation requests sent to reviewers2024-02-28Scientific triage completed2024-02-28In scientific triage2024-02-28Manuscript accepted for processing2024-02-28Plagiarism check (submission) 1 ready2024-02-28Sent for anti-plagiarism verification2024-02-28Submissions Approved2024-02-27Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Mar 14 01:54:59 CST 2024, time=2024-03-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2192320, encodeId=a44621923203b, content=投稿命中率:95.0<br>偏重的研究方向:临床研究<br>经验分享:2023-10-25 Paid 2023-10-24 Accepted - invoice issued 2023-10-24 1st Post-Rev plagiarism check ready 2023-10-24 Sent for 1st Post-Rev antiplagiarism check 2023-10-24 Ready for Post-Rev antiplagiarism check 2023-10-24 Awaiting decision 2023-10-23 Review 2 pending 2023-10-23 Review 2 requests sent to reviewers 2023-10-21 After authors corrections 2023-10-09 Sent to author(s) for corrections (2 weeks) 2023-10-09 Reconsider after revision 2023-10-09 Awaiting decision 2023-10-09 2nd Scientific Triage Completed 2023-10-09 In 2nd Scientific triage 2023-10-06 Review pending 2023-10-03 Evaluation requests sent to reviewers 2023-09-23 Review pending 2023-08-31 Evaluation requests sent to reviewers 2023-08-29 Scientific triage completed 2023-08-29 In scientific triage 2023-08-29 Manuscript accepted for processing 2023-08-28 Plagiarism check (submission) 1 ready 2023-08-28 Sent for anti-plagiarism verification 2023-08-28 Submissions Approved 2023-08-28 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Sun Mar 10 00:10:47 CST 2024, time=2024-03-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190508, encodeId=970e219050833, content=在线等,急,请问让转投的Clinical Practice Review and Meta-Analysis这是本什么期刊?pubmed和Web of science都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Fri Mar 01 23:06:35 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2170547, encodeId=f97c21e054770, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综合<br>经验分享:从投到接收不到2个月,总的来说挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Nov 23 17:12:17 CST 2023, time=2023-11-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189743, encodeId=19892189e4301, content=审稿速度:6.0<br>经验分享:2024-02-25<br>Rejected - suggested journal transfer<br>Note: suggested_to Clinical Practice Review and Meta-Analysis<br>2024-01-15<br>Awaiting decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=大星猩, createdTime=Tue Feb 27 20:38:13 CST 2024, time=2024-02-27, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2189494, encodeId=5e8d21894944c, content=它让我转投Clinical Practice Review and Meta-Analysis,我搜都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Mon Feb 26 18:11:00 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189661, encodeId=53cc21896616d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:返修后杂志说crossed out text should be removed, blinded files should be uploaded, same applies to the response letter.到底是啥意思啊?有没有大佬知道的啊,着急死了。上传网页之前上传的文件是删不掉的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14388513788, createdName=ms4000000240525001, createdTime=Tue Feb 27 14:04:42 CST 2024, time=2024-02-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=573054, encodeId=d3855e305470, content=2019-06-27 - Sent to author for corrections (post-review verification) <br> Note: Your anti-plagiarism report is ready. Your manuscript has shown some degree of similarity to previously published material. Please reduce the similarity and rewrite your text where indicated. Be sure that all source material is properly cited and listed in the bibliography. You may upload your revised manuscript when ready. You will find the report in "Antiplagiarism Report" Tab in your Authors Account. <br> 2019-06-27 - After 1st post-review antiplagiarism verification <br> 2019-06-27 - Sent for 1st post-review antiplagiarism verification <br> 2019-06-27 - Ready for post-review antiplagiarism verification <br> 2019-06-27 - Awaiting decision <br> 2019-05-31 - Review 2 pending <br> 2019-05-31 - Review 2 requests sent to reviewers <br> 2019-05-08 - After authors corrections <br> 2019-05-01 - Sent to author for corrections (3 weeks) <br> 2019-05-01 - Reconsider after revision <br> 2019-04-30 - Awaiting decision <br> 2019-04-30 - 2nd Scientific Triage Completed <br> 2019-04-30 - In 2nd Scientific triage <br> 2019-04-18 - Review pending <br> 2019-04-18 - Evaluation requests sent to reviewers <br> 2019-04-17 - Unlocked <br> Note: Author uploaded new file. <br> 2019-04-16 - On hold <br> Note: Please provide us with legends for tables. Also, the entire file, containing all figures and tables, but without information about authors, should be uploaded for the review process. <br> 2019-04-15 - After scientific triage <br> 2019-04-14 - In scientific triage <br> 2019-04-14 - Manuscript accepted for processing <br> 2019-04-12 - Manuscript CrossChecked <br> 2019-04-12 - Sent for Plagiarism CrossCheck <br> 2019-04-12 - Submission Approved <br> 2019-04-12 - Incomplete, correction file uploaded <br> 2019-04-12 - Incomplete, waiting for authors reply <br> Note: The details in the message <br> 2019-04-12 - Incomplete, correction file uploaded <br> 2019-04-11 - Incomplete, waiting for authors reply <br> Note: The details in the message <br> 2019-04-11 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BSVB1WwY0QcChXdZibhTw8u2dzBZ0WtAodehibxMzLASJ1QbQd7oS4r1jvLfn5Eic4ID4qAkQTj55EmbFOHhJZ1rQ/132, createdBy=3bf32416063, createdName=912391303_75271680, createdTime=Fri Jun 28 10:47:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588261, encodeId=8b645882610c, content=您最后文章怎么样了?我也是这个状态<span class="quote">李医生 2020-02-24 00:00:00 发表:<br>你好,请问一下我已经到第三个黑框框了,上面显示 in 2nd scientific traige, review pending已经过去了,这代表什么意思,如果可以的话麻烦您能写一下您在投稿到接受之间的具体流程</span>, beContent=李医生 2020-02-24 00:00:00 发表: 你好,请问一下我已经到第三个黑框框了,上面显示 in 2nd scientific traige, review pending已经过去了,这代表什么意思,如果可以的话麻烦您能写一下您在投稿到接受之间的具体流程, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/E8F0816F065B9BD94C3C0E9796895C76/100, createdBy=c5142399843, createdName=CR7, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170968, encodeId=7ee421e0968b0, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:实在太难投了,根本没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bd8583610, createdName=ms8000002106570968, createdTime=Sat Nov 25 21:10:05 CST 2023, time=2023-11-25, status=1, ipAttribution=湖北省)]
    2024-03-10 ms5000000983971375 来自陕西省

    投稿命中率:95.0
    偏重的研究方向:临床研究
    经验分享:2023-10-25 Paid 2023-10-24 Accepted - invoice issued 2023-10-24 1st Post-Rev plagiarism check ready 2023-10-24 Sent for 1st Post-Rev antiplagiarism check 2023-10-24 Ready for Post-Rev antiplagiarism check 2023-10-24 Awaiting decision 2023-10-23 Review 2 pending 2023-10-23 Review 2 requests sent to reviewers 2023-10-21 After authors corrections 2023-10-09 Sent to author(s) for corrections (2 weeks) 2023-10-09 Reconsider after revision 2023-10-09 Awaiting decision 2023-10-09 2nd Scientific Triage Completed 2023-10-09 In 2nd Scientific triage 2023-10-06 Review pending 2023-10-03 Evaluation requests sent to reviewers 2023-09-23 Review pending 2023-08-31 Evaluation requests sent to reviewers 2023-08-29 Scientific triage completed 2023-08-29 In scientific triage 2023-08-29 Manuscript accepted for processing 2023-08-28 Plagiarism check (submission) 1 ready 2023-08-28 Sent for anti-plagiarism verification 2023-08-28 Submissions Approved 2023-08-28 Submission Received

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2193071, encodeId=8f9921930e1ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床研究;科研<br>经验分享:2024-03-12Rejected2024-03-12Review - rejected2024-03-11Awaiting decision2024-03-112nd Scientific Triage Completed2024-03-11In 2nd Scientific triage2024-02-29Review pending2024-02-29Evaluation requests sent to reviewers2024-02-28Scientific triage completed2024-02-28In scientific triage2024-02-28Manuscript accepted for processing2024-02-28Plagiarism check (submission) 1 ready2024-02-28Sent for anti-plagiarism verification2024-02-28Submissions Approved2024-02-27Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Mar 14 01:54:59 CST 2024, time=2024-03-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2192320, encodeId=a44621923203b, content=投稿命中率:95.0<br>偏重的研究方向:临床研究<br>经验分享:2023-10-25 Paid 2023-10-24 Accepted - invoice issued 2023-10-24 1st Post-Rev plagiarism check ready 2023-10-24 Sent for 1st Post-Rev antiplagiarism check 2023-10-24 Ready for Post-Rev antiplagiarism check 2023-10-24 Awaiting decision 2023-10-23 Review 2 pending 2023-10-23 Review 2 requests sent to reviewers 2023-10-21 After authors corrections 2023-10-09 Sent to author(s) for corrections (2 weeks) 2023-10-09 Reconsider after revision 2023-10-09 Awaiting decision 2023-10-09 2nd Scientific Triage Completed 2023-10-09 In 2nd Scientific triage 2023-10-06 Review pending 2023-10-03 Evaluation requests sent to reviewers 2023-09-23 Review pending 2023-08-31 Evaluation requests sent to reviewers 2023-08-29 Scientific triage completed 2023-08-29 In scientific triage 2023-08-29 Manuscript accepted for processing 2023-08-28 Plagiarism check (submission) 1 ready 2023-08-28 Sent for anti-plagiarism verification 2023-08-28 Submissions Approved 2023-08-28 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Sun Mar 10 00:10:47 CST 2024, time=2024-03-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190508, encodeId=970e219050833, content=在线等,急,请问让转投的Clinical Practice Review and Meta-Analysis这是本什么期刊?pubmed和Web of science都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Fri Mar 01 23:06:35 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2170547, encodeId=f97c21e054770, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综合<br>经验分享:从投到接收不到2个月,总的来说挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Nov 23 17:12:17 CST 2023, time=2023-11-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189743, encodeId=19892189e4301, content=审稿速度:6.0<br>经验分享:2024-02-25<br>Rejected - suggested journal transfer<br>Note: suggested_to Clinical Practice Review and Meta-Analysis<br>2024-01-15<br>Awaiting decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=大星猩, createdTime=Tue Feb 27 20:38:13 CST 2024, time=2024-02-27, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2189494, encodeId=5e8d21894944c, content=它让我转投Clinical Practice Review and Meta-Analysis,我搜都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Mon Feb 26 18:11:00 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189661, encodeId=53cc21896616d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:返修后杂志说crossed out text should be removed, blinded files should be uploaded, same applies to the response letter.到底是啥意思啊?有没有大佬知道的啊,着急死了。上传网页之前上传的文件是删不掉的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14388513788, createdName=ms4000000240525001, createdTime=Tue Feb 27 14:04:42 CST 2024, time=2024-02-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=573054, encodeId=d3855e305470, content=2019-06-27 - Sent to author for corrections (post-review verification) <br> Note: Your anti-plagiarism report is ready. Your manuscript has shown some degree of similarity to previously published material. Please reduce the similarity and rewrite your text where indicated. Be sure that all source material is properly cited and listed in the bibliography. You may upload your revised manuscript when ready. You will find the report in "Antiplagiarism Report" Tab in your Authors Account. <br> 2019-06-27 - After 1st post-review antiplagiarism verification <br> 2019-06-27 - Sent for 1st post-review antiplagiarism verification <br> 2019-06-27 - Ready for post-review antiplagiarism verification <br> 2019-06-27 - Awaiting decision <br> 2019-05-31 - Review 2 pending <br> 2019-05-31 - Review 2 requests sent to reviewers <br> 2019-05-08 - After authors corrections <br> 2019-05-01 - Sent to author for corrections (3 weeks) <br> 2019-05-01 - Reconsider after revision <br> 2019-04-30 - Awaiting decision <br> 2019-04-30 - 2nd Scientific Triage Completed <br> 2019-04-30 - In 2nd Scientific triage <br> 2019-04-18 - Review pending <br> 2019-04-18 - Evaluation requests sent to reviewers <br> 2019-04-17 - Unlocked <br> Note: Author uploaded new file. <br> 2019-04-16 - On hold <br> Note: Please provide us with legends for tables. Also, the entire file, containing all figures and tables, but without information about authors, should be uploaded for the review process. <br> 2019-04-15 - After scientific triage <br> 2019-04-14 - In scientific triage <br> 2019-04-14 - Manuscript accepted for processing <br> 2019-04-12 - Manuscript CrossChecked <br> 2019-04-12 - Sent for Plagiarism CrossCheck <br> 2019-04-12 - Submission Approved <br> 2019-04-12 - Incomplete, correction file uploaded <br> 2019-04-12 - Incomplete, waiting for authors reply <br> Note: The details in the message <br> 2019-04-12 - Incomplete, correction file uploaded <br> 2019-04-11 - Incomplete, waiting for authors reply <br> Note: The details in the message <br> 2019-04-11 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BSVB1WwY0QcChXdZibhTw8u2dzBZ0WtAodehibxMzLASJ1QbQd7oS4r1jvLfn5Eic4ID4qAkQTj55EmbFOHhJZ1rQ/132, createdBy=3bf32416063, createdName=912391303_75271680, createdTime=Fri Jun 28 10:47:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588261, encodeId=8b645882610c, content=您最后文章怎么样了?我也是这个状态<span class="quote">李医生 2020-02-24 00:00:00 发表:<br>你好,请问一下我已经到第三个黑框框了,上面显示 in 2nd scientific traige, review pending已经过去了,这代表什么意思,如果可以的话麻烦您能写一下您在投稿到接受之间的具体流程</span>, beContent=李医生 2020-02-24 00:00:00 发表: 你好,请问一下我已经到第三个黑框框了,上面显示 in 2nd scientific traige, review pending已经过去了,这代表什么意思,如果可以的话麻烦您能写一下您在投稿到接受之间的具体流程, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/E8F0816F065B9BD94C3C0E9796895C76/100, createdBy=c5142399843, createdName=CR7, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170968, encodeId=7ee421e0968b0, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:实在太难投了,根本没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bd8583610, createdName=ms8000002106570968, createdTime=Sat Nov 25 21:10:05 CST 2023, time=2023-11-25, status=1, ipAttribution=湖北省)]
    2024-03-01 Unparalled 来自浙江省

    在线等,急,请问让转投的Clinical Practice Review and Meta-Analysis这是本什么期刊?pubmed和Web of science都搜不到

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2193071, encodeId=8f9921930e1ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床研究;科研<br>经验分享:2024-03-12Rejected2024-03-12Review - rejected2024-03-11Awaiting decision2024-03-112nd Scientific Triage Completed2024-03-11In 2nd Scientific triage2024-02-29Review pending2024-02-29Evaluation requests sent to reviewers2024-02-28Scientific triage completed2024-02-28In scientific triage2024-02-28Manuscript accepted for processing2024-02-28Plagiarism check (submission) 1 ready2024-02-28Sent for anti-plagiarism verification2024-02-28Submissions Approved2024-02-27Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Mar 14 01:54:59 CST 2024, time=2024-03-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2192320, encodeId=a44621923203b, content=投稿命中率:95.0<br>偏重的研究方向:临床研究<br>经验分享:2023-10-25 Paid 2023-10-24 Accepted - invoice issued 2023-10-24 1st Post-Rev plagiarism check ready 2023-10-24 Sent for 1st Post-Rev antiplagiarism check 2023-10-24 Ready for Post-Rev antiplagiarism check 2023-10-24 Awaiting decision 2023-10-23 Review 2 pending 2023-10-23 Review 2 requests sent to reviewers 2023-10-21 After authors corrections 2023-10-09 Sent to author(s) for corrections (2 weeks) 2023-10-09 Reconsider after revision 2023-10-09 Awaiting decision 2023-10-09 2nd Scientific Triage Completed 2023-10-09 In 2nd Scientific triage 2023-10-06 Review pending 2023-10-03 Evaluation requests sent to reviewers 2023-09-23 Review pending 2023-08-31 Evaluation requests sent to reviewers 2023-08-29 Scientific triage completed 2023-08-29 In scientific triage 2023-08-29 Manuscript accepted for processing 2023-08-28 Plagiarism check (submission) 1 ready 2023-08-28 Sent for anti-plagiarism verification 2023-08-28 Submissions Approved 2023-08-28 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Sun Mar 10 00:10:47 CST 2024, time=2024-03-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190508, encodeId=970e219050833, content=在线等,急,请问让转投的Clinical Practice Review and Meta-Analysis这是本什么期刊?pubmed和Web of science都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Fri Mar 01 23:06:35 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2170547, encodeId=f97c21e054770, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综合<br>经验分享:从投到接收不到2个月,总的来说挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Nov 23 17:12:17 CST 2023, time=2023-11-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189743, encodeId=19892189e4301, content=审稿速度:6.0<br>经验分享:2024-02-25<br>Rejected - suggested journal transfer<br>Note: suggested_to Clinical Practice Review and Meta-Analysis<br>2024-01-15<br>Awaiting decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=大星猩, createdTime=Tue Feb 27 20:38:13 CST 2024, time=2024-02-27, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2189494, encodeId=5e8d21894944c, content=它让我转投Clinical Practice Review and Meta-Analysis,我搜都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Mon Feb 26 18:11:00 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189661, encodeId=53cc21896616d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:返修后杂志说crossed out text should be removed, blinded files should be uploaded, same applies to the response letter.到底是啥意思啊?有没有大佬知道的啊,着急死了。上传网页之前上传的文件是删不掉的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14388513788, createdName=ms4000000240525001, createdTime=Tue Feb 27 14:04:42 CST 2024, time=2024-02-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=573054, encodeId=d3855e305470, content=2019-06-27 - Sent to author for corrections (post-review verification) <br> Note: Your anti-plagiarism report is ready. Your manuscript has shown some degree of similarity to previously published material. Please reduce the similarity and rewrite your text where indicated. Be sure that all source material is properly cited and listed in the bibliography. You may upload your revised manuscript when ready. You will find the report in "Antiplagiarism Report" Tab in your Authors Account. <br> 2019-06-27 - After 1st post-review antiplagiarism verification <br> 2019-06-27 - Sent for 1st post-review antiplagiarism verification <br> 2019-06-27 - Ready for post-review antiplagiarism verification <br> 2019-06-27 - Awaiting decision <br> 2019-05-31 - Review 2 pending <br> 2019-05-31 - Review 2 requests sent to reviewers <br> 2019-05-08 - After authors corrections <br> 2019-05-01 - Sent to author for corrections (3 weeks) <br> 2019-05-01 - Reconsider after revision <br> 2019-04-30 - Awaiting decision <br> 2019-04-30 - 2nd Scientific Triage Completed <br> 2019-04-30 - In 2nd Scientific triage <br> 2019-04-18 - Review pending <br> 2019-04-18 - Evaluation requests sent to reviewers <br> 2019-04-17 - Unlocked <br> Note: Author uploaded new file. <br> 2019-04-16 - On hold <br> Note: Please provide us with legends for tables. Also, the entire file, containing all figures and tables, but without information about authors, should be uploaded for the review process. <br> 2019-04-15 - After scientific triage <br> 2019-04-14 - In scientific triage <br> 2019-04-14 - Manuscript accepted for processing <br> 2019-04-12 - Manuscript CrossChecked <br> 2019-04-12 - Sent for Plagiarism CrossCheck <br> 2019-04-12 - Submission Approved <br> 2019-04-12 - Incomplete, correction file uploaded <br> 2019-04-12 - Incomplete, waiting for authors reply <br> Note: The details in the message <br> 2019-04-12 - Incomplete, correction file uploaded <br> 2019-04-11 - Incomplete, waiting for authors reply <br> Note: The details in the message <br> 2019-04-11 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BSVB1WwY0QcChXdZibhTw8u2dzBZ0WtAodehibxMzLASJ1QbQd7oS4r1jvLfn5Eic4ID4qAkQTj55EmbFOHhJZ1rQ/132, createdBy=3bf32416063, createdName=912391303_75271680, createdTime=Fri Jun 28 10:47:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588261, encodeId=8b645882610c, content=您最后文章怎么样了?我也是这个状态<span class="quote">李医生 2020-02-24 00:00:00 发表:<br>你好,请问一下我已经到第三个黑框框了,上面显示 in 2nd scientific traige, review pending已经过去了,这代表什么意思,如果可以的话麻烦您能写一下您在投稿到接受之间的具体流程</span>, beContent=李医生 2020-02-24 00:00:00 发表: 你好,请问一下我已经到第三个黑框框了,上面显示 in 2nd scientific traige, review pending已经过去了,这代表什么意思,如果可以的话麻烦您能写一下您在投稿到接受之间的具体流程, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/E8F0816F065B9BD94C3C0E9796895C76/100, createdBy=c5142399843, createdName=CR7, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170968, encodeId=7ee421e0968b0, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:实在太难投了,根本没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bd8583610, createdName=ms8000002106570968, createdTime=Sat Nov 25 21:10:05 CST 2023, time=2023-11-25, status=1, ipAttribution=湖北省)]
    2023-11-23 ms5000000983971375 来自陕西省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:综合
    经验分享:从投到接收不到2个月,总的来说挺快的

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2193071, encodeId=8f9921930e1ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床研究;科研<br>经验分享:2024-03-12Rejected2024-03-12Review - rejected2024-03-11Awaiting decision2024-03-112nd Scientific Triage Completed2024-03-11In 2nd Scientific triage2024-02-29Review pending2024-02-29Evaluation requests sent to reviewers2024-02-28Scientific triage completed2024-02-28In scientific triage2024-02-28Manuscript accepted for processing2024-02-28Plagiarism check (submission) 1 ready2024-02-28Sent for anti-plagiarism verification2024-02-28Submissions Approved2024-02-27Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Mar 14 01:54:59 CST 2024, time=2024-03-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2192320, encodeId=a44621923203b, content=投稿命中率:95.0<br>偏重的研究方向:临床研究<br>经验分享:2023-10-25 Paid 2023-10-24 Accepted - invoice issued 2023-10-24 1st Post-Rev plagiarism check ready 2023-10-24 Sent for 1st Post-Rev antiplagiarism check 2023-10-24 Ready for Post-Rev antiplagiarism check 2023-10-24 Awaiting decision 2023-10-23 Review 2 pending 2023-10-23 Review 2 requests sent to reviewers 2023-10-21 After authors corrections 2023-10-09 Sent to author(s) for corrections (2 weeks) 2023-10-09 Reconsider after revision 2023-10-09 Awaiting decision 2023-10-09 2nd Scientific Triage Completed 2023-10-09 In 2nd Scientific triage 2023-10-06 Review pending 2023-10-03 Evaluation requests sent to reviewers 2023-09-23 Review pending 2023-08-31 Evaluation requests sent to reviewers 2023-08-29 Scientific triage completed 2023-08-29 In scientific triage 2023-08-29 Manuscript accepted for processing 2023-08-28 Plagiarism check (submission) 1 ready 2023-08-28 Sent for anti-plagiarism verification 2023-08-28 Submissions Approved 2023-08-28 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Sun Mar 10 00:10:47 CST 2024, time=2024-03-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190508, encodeId=970e219050833, content=在线等,急,请问让转投的Clinical Practice Review and Meta-Analysis这是本什么期刊?pubmed和Web of science都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Fri Mar 01 23:06:35 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2170547, encodeId=f97c21e054770, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综合<br>经验分享:从投到接收不到2个月,总的来说挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Nov 23 17:12:17 CST 2023, time=2023-11-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189743, encodeId=19892189e4301, content=审稿速度:6.0<br>经验分享:2024-02-25<br>Rejected - suggested journal transfer<br>Note: suggested_to Clinical Practice Review and Meta-Analysis<br>2024-01-15<br>Awaiting decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=大星猩, createdTime=Tue Feb 27 20:38:13 CST 2024, time=2024-02-27, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2189494, encodeId=5e8d21894944c, content=它让我转投Clinical Practice Review and Meta-Analysis,我搜都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Mon Feb 26 18:11:00 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189661, encodeId=53cc21896616d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:返修后杂志说crossed out text should be removed, blinded files should be uploaded, same applies to the response letter.到底是啥意思啊?有没有大佬知道的啊,着急死了。上传网页之前上传的文件是删不掉的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14388513788, createdName=ms4000000240525001, createdTime=Tue Feb 27 14:04:42 CST 2024, time=2024-02-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=573054, encodeId=d3855e305470, content=2019-06-27 - Sent to author for corrections (post-review verification) <br> Note: Your anti-plagiarism report is ready. Your manuscript has shown some degree of similarity to previously published material. Please reduce the similarity and rewrite your text where indicated. Be sure that all source material is properly cited and listed in the bibliography. You may upload your revised manuscript when ready. You will find the report in "Antiplagiarism Report" Tab in your Authors Account. <br> 2019-06-27 - After 1st post-review antiplagiarism verification <br> 2019-06-27 - Sent for 1st post-review antiplagiarism verification <br> 2019-06-27 - Ready for post-review antiplagiarism verification <br> 2019-06-27 - Awaiting decision <br> 2019-05-31 - Review 2 pending <br> 2019-05-31 - Review 2 requests sent to reviewers <br> 2019-05-08 - After authors corrections <br> 2019-05-01 - Sent to author for corrections (3 weeks) <br> 2019-05-01 - Reconsider after revision <br> 2019-04-30 - Awaiting decision <br> 2019-04-30 - 2nd Scientific Triage Completed <br> 2019-04-30 - In 2nd Scientific triage <br> 2019-04-18 - Review pending <br> 2019-04-18 - Evaluation requests sent to reviewers <br> 2019-04-17 - Unlocked <br> Note: Author uploaded new file. <br> 2019-04-16 - On hold <br> Note: Please provide us with legends for tables. Also, the entire file, containing all figures and tables, but without information about authors, should be uploaded for the review process. <br> 2019-04-15 - After scientific triage <br> 2019-04-14 - In scientific triage <br> 2019-04-14 - Manuscript accepted for processing <br> 2019-04-12 - Manuscript CrossChecked <br> 2019-04-12 - Sent for Plagiarism CrossCheck <br> 2019-04-12 - Submission Approved <br> 2019-04-12 - Incomplete, correction file uploaded <br> 2019-04-12 - Incomplete, waiting for authors reply <br> Note: The details in the message <br> 2019-04-12 - Incomplete, correction file uploaded <br> 2019-04-11 - Incomplete, waiting for authors reply <br> Note: The details in the message <br> 2019-04-11 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BSVB1WwY0QcChXdZibhTw8u2dzBZ0WtAodehibxMzLASJ1QbQd7oS4r1jvLfn5Eic4ID4qAkQTj55EmbFOHhJZ1rQ/132, createdBy=3bf32416063, createdName=912391303_75271680, createdTime=Fri Jun 28 10:47:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588261, encodeId=8b645882610c, content=您最后文章怎么样了?我也是这个状态<span class="quote">李医生 2020-02-24 00:00:00 发表:<br>你好,请问一下我已经到第三个黑框框了,上面显示 in 2nd scientific traige, review pending已经过去了,这代表什么意思,如果可以的话麻烦您能写一下您在投稿到接受之间的具体流程</span>, beContent=李医生 2020-02-24 00:00:00 发表: 你好,请问一下我已经到第三个黑框框了,上面显示 in 2nd scientific traige, review pending已经过去了,这代表什么意思,如果可以的话麻烦您能写一下您在投稿到接受之间的具体流程, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/E8F0816F065B9BD94C3C0E9796895C76/100, createdBy=c5142399843, createdName=CR7, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170968, encodeId=7ee421e0968b0, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:实在太难投了,根本没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bd8583610, createdName=ms8000002106570968, createdTime=Sat Nov 25 21:10:05 CST 2023, time=2023-11-25, status=1, ipAttribution=湖北省)]
    2024-02-27 大星猩 来自东京都

    审稿速度:6.0
    经验分享:2024-02-25
    Rejected - suggested journal transfer
    Note: suggested_to Clinical Practice Review and Meta-Analysis
    2024-01-15
    Awaiting decision

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2193071, encodeId=8f9921930e1ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床研究;科研<br>经验分享:2024-03-12Rejected2024-03-12Review - rejected2024-03-11Awaiting decision2024-03-112nd Scientific Triage Completed2024-03-11In 2nd Scientific triage2024-02-29Review pending2024-02-29Evaluation requests sent to reviewers2024-02-28Scientific triage completed2024-02-28In scientific triage2024-02-28Manuscript accepted for processing2024-02-28Plagiarism check (submission) 1 ready2024-02-28Sent for anti-plagiarism verification2024-02-28Submissions Approved2024-02-27Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Mar 14 01:54:59 CST 2024, time=2024-03-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2192320, encodeId=a44621923203b, content=投稿命中率:95.0<br>偏重的研究方向:临床研究<br>经验分享:2023-10-25 Paid 2023-10-24 Accepted - invoice issued 2023-10-24 1st Post-Rev plagiarism check ready 2023-10-24 Sent for 1st Post-Rev antiplagiarism check 2023-10-24 Ready for Post-Rev antiplagiarism check 2023-10-24 Awaiting decision 2023-10-23 Review 2 pending 2023-10-23 Review 2 requests sent to reviewers 2023-10-21 After authors corrections 2023-10-09 Sent to author(s) for corrections (2 weeks) 2023-10-09 Reconsider after revision 2023-10-09 Awaiting decision 2023-10-09 2nd Scientific Triage Completed 2023-10-09 In 2nd Scientific triage 2023-10-06 Review pending 2023-10-03 Evaluation requests sent to reviewers 2023-09-23 Review pending 2023-08-31 Evaluation requests sent to reviewers 2023-08-29 Scientific triage completed 2023-08-29 In scientific triage 2023-08-29 Manuscript accepted for processing 2023-08-28 Plagiarism check (submission) 1 ready 2023-08-28 Sent for anti-plagiarism verification 2023-08-28 Submissions Approved 2023-08-28 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Sun Mar 10 00:10:47 CST 2024, time=2024-03-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190508, encodeId=970e219050833, content=在线等,急,请问让转投的Clinical Practice Review and Meta-Analysis这是本什么期刊?pubmed和Web of science都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Fri Mar 01 23:06:35 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2170547, encodeId=f97c21e054770, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综合<br>经验分享:从投到接收不到2个月,总的来说挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Nov 23 17:12:17 CST 2023, time=2023-11-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189743, encodeId=19892189e4301, content=审稿速度:6.0<br>经验分享:2024-02-25<br>Rejected - suggested journal transfer<br>Note: suggested_to Clinical Practice Review and Meta-Analysis<br>2024-01-15<br>Awaiting decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=大星猩, createdTime=Tue Feb 27 20:38:13 CST 2024, time=2024-02-27, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2189494, encodeId=5e8d21894944c, content=它让我转投Clinical Practice Review and Meta-Analysis,我搜都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Mon Feb 26 18:11:00 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189661, encodeId=53cc21896616d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:返修后杂志说crossed out text should be removed, blinded files should be uploaded, same applies to the response letter.到底是啥意思啊?有没有大佬知道的啊,着急死了。上传网页之前上传的文件是删不掉的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14388513788, createdName=ms4000000240525001, createdTime=Tue Feb 27 14:04:42 CST 2024, time=2024-02-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=573054, encodeId=d3855e305470, content=2019-06-27 - Sent to author for corrections (post-review verification) <br> Note: Your anti-plagiarism report is ready. Your manuscript has shown some degree of similarity to previously published material. Please reduce the similarity and rewrite your text where indicated. Be sure that all source material is properly cited and listed in the bibliography. You may upload your revised manuscript when ready. You will find the report in "Antiplagiarism Report" Tab in your Authors Account. <br> 2019-06-27 - After 1st post-review antiplagiarism verification <br> 2019-06-27 - Sent for 1st post-review antiplagiarism verification <br> 2019-06-27 - Ready for post-review antiplagiarism verification <br> 2019-06-27 - Awaiting decision <br> 2019-05-31 - Review 2 pending <br> 2019-05-31 - Review 2 requests sent to reviewers <br> 2019-05-08 - After authors corrections <br> 2019-05-01 - Sent to author for corrections (3 weeks) <br> 2019-05-01 - Reconsider after revision <br> 2019-04-30 - Awaiting decision <br> 2019-04-30 - 2nd Scientific Triage Completed <br> 2019-04-30 - In 2nd Scientific triage <br> 2019-04-18 - Review pending <br> 2019-04-18 - Evaluation requests sent to reviewers <br> 2019-04-17 - Unlocked <br> Note: Author uploaded new file. <br> 2019-04-16 - On hold <br> Note: Please provide us with legends for tables. Also, the entire file, containing all figures and tables, but without information about authors, should be uploaded for the review process. <br> 2019-04-15 - After scientific triage <br> 2019-04-14 - In scientific triage <br> 2019-04-14 - Manuscript accepted for processing <br> 2019-04-12 - Manuscript CrossChecked <br> 2019-04-12 - Sent for Plagiarism CrossCheck <br> 2019-04-12 - Submission Approved <br> 2019-04-12 - Incomplete, correction file uploaded <br> 2019-04-12 - Incomplete, waiting for authors reply <br> Note: The details in the message <br> 2019-04-12 - Incomplete, correction file uploaded <br> 2019-04-11 - Incomplete, waiting for authors reply <br> Note: The details in the message <br> 2019-04-11 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BSVB1WwY0QcChXdZibhTw8u2dzBZ0WtAodehibxMzLASJ1QbQd7oS4r1jvLfn5Eic4ID4qAkQTj55EmbFOHhJZ1rQ/132, createdBy=3bf32416063, createdName=912391303_75271680, createdTime=Fri Jun 28 10:47:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588261, encodeId=8b645882610c, content=您最后文章怎么样了?我也是这个状态<span class="quote">李医生 2020-02-24 00:00:00 发表:<br>你好,请问一下我已经到第三个黑框框了,上面显示 in 2nd scientific traige, review pending已经过去了,这代表什么意思,如果可以的话麻烦您能写一下您在投稿到接受之间的具体流程</span>, beContent=李医生 2020-02-24 00:00:00 发表: 你好,请问一下我已经到第三个黑框框了,上面显示 in 2nd scientific traige, review pending已经过去了,这代表什么意思,如果可以的话麻烦您能写一下您在投稿到接受之间的具体流程, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/E8F0816F065B9BD94C3C0E9796895C76/100, createdBy=c5142399843, createdName=CR7, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170968, encodeId=7ee421e0968b0, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:实在太难投了,根本没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bd8583610, createdName=ms8000002106570968, createdTime=Sat Nov 25 21:10:05 CST 2023, time=2023-11-25, status=1, ipAttribution=湖北省)]
    2024-02-26 Unparalled 来自浙江省

    它让我转投Clinical Practice Review and Meta-Analysis,我搜都搜不到

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2193071, encodeId=8f9921930e1ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床研究;科研<br>经验分享:2024-03-12Rejected2024-03-12Review - rejected2024-03-11Awaiting decision2024-03-112nd Scientific Triage Completed2024-03-11In 2nd Scientific triage2024-02-29Review pending2024-02-29Evaluation requests sent to reviewers2024-02-28Scientific triage completed2024-02-28In scientific triage2024-02-28Manuscript accepted for processing2024-02-28Plagiarism check (submission) 1 ready2024-02-28Sent for anti-plagiarism verification2024-02-28Submissions Approved2024-02-27Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Mar 14 01:54:59 CST 2024, time=2024-03-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2192320, encodeId=a44621923203b, content=投稿命中率:95.0<br>偏重的研究方向:临床研究<br>经验分享:2023-10-25 Paid 2023-10-24 Accepted - invoice issued 2023-10-24 1st Post-Rev plagiarism check ready 2023-10-24 Sent for 1st Post-Rev antiplagiarism check 2023-10-24 Ready for Post-Rev antiplagiarism check 2023-10-24 Awaiting decision 2023-10-23 Review 2 pending 2023-10-23 Review 2 requests sent to reviewers 2023-10-21 After authors corrections 2023-10-09 Sent to author(s) for corrections (2 weeks) 2023-10-09 Reconsider after revision 2023-10-09 Awaiting decision 2023-10-09 2nd Scientific Triage Completed 2023-10-09 In 2nd Scientific triage 2023-10-06 Review pending 2023-10-03 Evaluation requests sent to reviewers 2023-09-23 Review pending 2023-08-31 Evaluation requests sent to reviewers 2023-08-29 Scientific triage completed 2023-08-29 In scientific triage 2023-08-29 Manuscript accepted for processing 2023-08-28 Plagiarism check (submission) 1 ready 2023-08-28 Sent for anti-plagiarism verification 2023-08-28 Submissions Approved 2023-08-28 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Sun Mar 10 00:10:47 CST 2024, time=2024-03-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190508, encodeId=970e219050833, content=在线等,急,请问让转投的Clinical Practice Review and Meta-Analysis这是本什么期刊?pubmed和Web of science都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Fri Mar 01 23:06:35 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2170547, encodeId=f97c21e054770, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综合<br>经验分享:从投到接收不到2个月,总的来说挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Nov 23 17:12:17 CST 2023, time=2023-11-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189743, encodeId=19892189e4301, content=审稿速度:6.0<br>经验分享:2024-02-25<br>Rejected - suggested journal transfer<br>Note: suggested_to Clinical Practice Review and Meta-Analysis<br>2024-01-15<br>Awaiting decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=大星猩, createdTime=Tue Feb 27 20:38:13 CST 2024, time=2024-02-27, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2189494, encodeId=5e8d21894944c, content=它让我转投Clinical Practice Review and Meta-Analysis,我搜都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Mon Feb 26 18:11:00 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189661, encodeId=53cc21896616d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:返修后杂志说crossed out text should be removed, blinded files should be uploaded, same applies to the response letter.到底是啥意思啊?有没有大佬知道的啊,着急死了。上传网页之前上传的文件是删不掉的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14388513788, createdName=ms4000000240525001, createdTime=Tue Feb 27 14:04:42 CST 2024, time=2024-02-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=573054, encodeId=d3855e305470, content=2019-06-27 - Sent to author for corrections (post-review verification) <br> Note: Your anti-plagiarism report is ready. Your manuscript has shown some degree of similarity to previously published material. Please reduce the similarity and rewrite your text where indicated. Be sure that all source material is properly cited and listed in the bibliography. You may upload your revised manuscript when ready. You will find the report in "Antiplagiarism Report" Tab in your Authors Account. <br> 2019-06-27 - After 1st post-review antiplagiarism verification <br> 2019-06-27 - Sent for 1st post-review antiplagiarism verification <br> 2019-06-27 - Ready for post-review antiplagiarism verification <br> 2019-06-27 - Awaiting decision <br> 2019-05-31 - Review 2 pending <br> 2019-05-31 - Review 2 requests sent to reviewers <br> 2019-05-08 - After authors corrections <br> 2019-05-01 - Sent to author for corrections (3 weeks) <br> 2019-05-01 - Reconsider after revision <br> 2019-04-30 - Awaiting decision <br> 2019-04-30 - 2nd Scientific Triage Completed <br> 2019-04-30 - In 2nd Scientific triage <br> 2019-04-18 - Review pending <br> 2019-04-18 - Evaluation requests sent to reviewers <br> 2019-04-17 - Unlocked <br> Note: Author uploaded new file. <br> 2019-04-16 - On hold <br> Note: Please provide us with legends for tables. Also, the entire file, containing all figures and tables, but without information about authors, should be uploaded for the review process. <br> 2019-04-15 - After scientific triage <br> 2019-04-14 - In scientific triage <br> 2019-04-14 - Manuscript accepted for processing <br> 2019-04-12 - Manuscript CrossChecked <br> 2019-04-12 - Sent for Plagiarism CrossCheck <br> 2019-04-12 - Submission Approved <br> 2019-04-12 - Incomplete, correction file uploaded <br> 2019-04-12 - Incomplete, waiting for authors reply <br> Note: The details in the message <br> 2019-04-12 - Incomplete, correction file uploaded <br> 2019-04-11 - Incomplete, waiting for authors reply <br> Note: The details in the message <br> 2019-04-11 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BSVB1WwY0QcChXdZibhTw8u2dzBZ0WtAodehibxMzLASJ1QbQd7oS4r1jvLfn5Eic4ID4qAkQTj55EmbFOHhJZ1rQ/132, createdBy=3bf32416063, createdName=912391303_75271680, createdTime=Fri Jun 28 10:47:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588261, encodeId=8b645882610c, content=您最后文章怎么样了?我也是这个状态<span class="quote">李医生 2020-02-24 00:00:00 发表:<br>你好,请问一下我已经到第三个黑框框了,上面显示 in 2nd scientific traige, review pending已经过去了,这代表什么意思,如果可以的话麻烦您能写一下您在投稿到接受之间的具体流程</span>, beContent=李医生 2020-02-24 00:00:00 发表: 你好,请问一下我已经到第三个黑框框了,上面显示 in 2nd scientific traige, review pending已经过去了,这代表什么意思,如果可以的话麻烦您能写一下您在投稿到接受之间的具体流程, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/E8F0816F065B9BD94C3C0E9796895C76/100, createdBy=c5142399843, createdName=CR7, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170968, encodeId=7ee421e0968b0, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:实在太难投了,根本没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bd8583610, createdName=ms8000002106570968, createdTime=Sat Nov 25 21:10:05 CST 2023, time=2023-11-25, status=1, ipAttribution=湖北省)]
    2024-02-27 ms4000000240525001 来自安徽省

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:返修后杂志说crossed out text should be removed, blinded files should be uploaded, same applies to the response letter.到底是啥意思啊?有没有大佬知道的啊,着急死了。上传网页之前上传的文件是删不掉的。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2193071, encodeId=8f9921930e1ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床研究;科研<br>经验分享:2024-03-12Rejected2024-03-12Review - rejected2024-03-11Awaiting decision2024-03-112nd Scientific Triage Completed2024-03-11In 2nd Scientific triage2024-02-29Review pending2024-02-29Evaluation requests sent to reviewers2024-02-28Scientific triage completed2024-02-28In scientific triage2024-02-28Manuscript accepted for processing2024-02-28Plagiarism check (submission) 1 ready2024-02-28Sent for anti-plagiarism verification2024-02-28Submissions Approved2024-02-27Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Mar 14 01:54:59 CST 2024, time=2024-03-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2192320, encodeId=a44621923203b, content=投稿命中率:95.0<br>偏重的研究方向:临床研究<br>经验分享:2023-10-25 Paid 2023-10-24 Accepted - invoice issued 2023-10-24 1st Post-Rev plagiarism check ready 2023-10-24 Sent for 1st Post-Rev antiplagiarism check 2023-10-24 Ready for Post-Rev antiplagiarism check 2023-10-24 Awaiting decision 2023-10-23 Review 2 pending 2023-10-23 Review 2 requests sent to reviewers 2023-10-21 After authors corrections 2023-10-09 Sent to author(s) for corrections (2 weeks) 2023-10-09 Reconsider after revision 2023-10-09 Awaiting decision 2023-10-09 2nd Scientific Triage Completed 2023-10-09 In 2nd Scientific triage 2023-10-06 Review pending 2023-10-03 Evaluation requests sent to reviewers 2023-09-23 Review pending 2023-08-31 Evaluation requests sent to reviewers 2023-08-29 Scientific triage completed 2023-08-29 In scientific triage 2023-08-29 Manuscript accepted for processing 2023-08-28 Plagiarism check (submission) 1 ready 2023-08-28 Sent for anti-plagiarism verification 2023-08-28 Submissions Approved 2023-08-28 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Sun Mar 10 00:10:47 CST 2024, time=2024-03-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190508, encodeId=970e219050833, content=在线等,急,请问让转投的Clinical Practice Review and Meta-Analysis这是本什么期刊?pubmed和Web of science都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Fri Mar 01 23:06:35 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2170547, encodeId=f97c21e054770, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综合<br>经验分享:从投到接收不到2个月,总的来说挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Nov 23 17:12:17 CST 2023, time=2023-11-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189743, encodeId=19892189e4301, content=审稿速度:6.0<br>经验分享:2024-02-25<br>Rejected - suggested journal transfer<br>Note: suggested_to Clinical Practice Review and Meta-Analysis<br>2024-01-15<br>Awaiting decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=大星猩, createdTime=Tue Feb 27 20:38:13 CST 2024, time=2024-02-27, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2189494, encodeId=5e8d21894944c, content=它让我转投Clinical Practice Review and Meta-Analysis,我搜都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Mon Feb 26 18:11:00 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189661, encodeId=53cc21896616d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:返修后杂志说crossed out text should be removed, blinded files should be uploaded, same applies to the response letter.到底是啥意思啊?有没有大佬知道的啊,着急死了。上传网页之前上传的文件是删不掉的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14388513788, createdName=ms4000000240525001, createdTime=Tue Feb 27 14:04:42 CST 2024, time=2024-02-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=573054, encodeId=d3855e305470, content=2019-06-27 - Sent to author for corrections (post-review verification) <br> Note: Your anti-plagiarism report is ready. Your manuscript has shown some degree of similarity to previously published material. Please reduce the similarity and rewrite your text where indicated. Be sure that all source material is properly cited and listed in the bibliography. You may upload your revised manuscript when ready. You will find the report in "Antiplagiarism Report" Tab in your Authors Account. <br> 2019-06-27 - After 1st post-review antiplagiarism verification <br> 2019-06-27 - Sent for 1st post-review antiplagiarism verification <br> 2019-06-27 - Ready for post-review antiplagiarism verification <br> 2019-06-27 - Awaiting decision <br> 2019-05-31 - Review 2 pending <br> 2019-05-31 - Review 2 requests sent to reviewers <br> 2019-05-08 - After authors corrections <br> 2019-05-01 - Sent to author for corrections (3 weeks) <br> 2019-05-01 - Reconsider after revision <br> 2019-04-30 - Awaiting decision <br> 2019-04-30 - 2nd Scientific Triage Completed <br> 2019-04-30 - In 2nd Scientific triage <br> 2019-04-18 - Review pending <br> 2019-04-18 - Evaluation requests sent to reviewers <br> 2019-04-17 - Unlocked <br> Note: Author uploaded new file. <br> 2019-04-16 - On hold <br> Note: Please provide us with legends for tables. Also, the entire file, containing all figures and tables, but without information about authors, should be uploaded for the review process. <br> 2019-04-15 - After scientific triage <br> 2019-04-14 - In scientific triage <br> 2019-04-14 - Manuscript accepted for processing <br> 2019-04-12 - Manuscript CrossChecked <br> 2019-04-12 - Sent for Plagiarism CrossCheck <br> 2019-04-12 - Submission Approved <br> 2019-04-12 - Incomplete, correction file uploaded <br> 2019-04-12 - Incomplete, waiting for authors reply <br> Note: The details in the message <br> 2019-04-12 - Incomplete, correction file uploaded <br> 2019-04-11 - Incomplete, waiting for authors reply <br> Note: The details in the message <br> 2019-04-11 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BSVB1WwY0QcChXdZibhTw8u2dzBZ0WtAodehibxMzLASJ1QbQd7oS4r1jvLfn5Eic4ID4qAkQTj55EmbFOHhJZ1rQ/132, createdBy=3bf32416063, createdName=912391303_75271680, createdTime=Fri Jun 28 10:47:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588261, encodeId=8b645882610c, content=您最后文章怎么样了?我也是这个状态<span class="quote">李医生 2020-02-24 00:00:00 发表:<br>你好,请问一下我已经到第三个黑框框了,上面显示 in 2nd scientific traige, review pending已经过去了,这代表什么意思,如果可以的话麻烦您能写一下您在投稿到接受之间的具体流程</span>, beContent=李医生 2020-02-24 00:00:00 发表: 你好,请问一下我已经到第三个黑框框了,上面显示 in 2nd scientific traige, review pending已经过去了,这代表什么意思,如果可以的话麻烦您能写一下您在投稿到接受之间的具体流程, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/E8F0816F065B9BD94C3C0E9796895C76/100, createdBy=c5142399843, createdName=CR7, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170968, encodeId=7ee421e0968b0, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:实在太难投了,根本没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bd8583610, createdName=ms8000002106570968, createdTime=Sat Nov 25 21:10:05 CST 2023, time=2023-11-25, status=1, ipAttribution=湖北省)]
    2019-06-28 912391303_75271680

    2019-06-27 - Sent to author for corrections (post-review verification)
    Note: Your anti-plagiarism report is ready. Your manuscript has shown some degree of similarity to previously published material. Please reduce the similarity and rewrite your text where indicated. Be sure that all source material is properly cited and listed in the bibliography. You may upload your revised manuscript when ready. You will find the report in "Antiplagiarism Report" Tab in your Authors Account.
    2019-06-27 - After 1st post-review antiplagiarism verification
    2019-06-27 - Sent for 1st post-review antiplagiarism verification
    2019-06-27 - Ready for post-review antiplagiarism verification
    2019-06-27 - Awaiting decision
    2019-05-31 - Review 2 pending
    2019-05-31 - Review 2 requests sent to reviewers
    2019-05-08 - After authors corrections
    2019-05-01 - Sent to author for corrections (3 weeks)
    2019-05-01 - Reconsider after revision
    2019-04-30 - Awaiting decision
    2019-04-30 - 2nd Scientific Triage Completed
    2019-04-30 - In 2nd Scientific triage
    2019-04-18 - Review pending
    2019-04-18 - Evaluation requests sent to reviewers
    2019-04-17 - Unlocked
    Note: Author uploaded new file.
    2019-04-16 - On hold
    Note: Please provide us with legends for tables. Also, the entire file, containing all figures and tables, but without information about authors, should be uploaded for the review process.
    2019-04-15 - After scientific triage
    2019-04-14 - In scientific triage
    2019-04-14 - Manuscript accepted for processing
    2019-04-12 - Manuscript CrossChecked
    2019-04-12 - Sent for Plagiarism CrossCheck
    2019-04-12 - Submission Approved
    2019-04-12 - Incomplete, correction file uploaded
    2019-04-12 - Incomplete, waiting for authors reply
    Note: The details in the message
    2019-04-12 - Incomplete, correction file uploaded
    2019-04-11 - Incomplete, waiting for authors reply
    Note: The details in the message
    2019-04-11 - Submission Received

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2193071, encodeId=8f9921930e1ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床研究;科研<br>经验分享:2024-03-12Rejected2024-03-12Review - rejected2024-03-11Awaiting decision2024-03-112nd Scientific Triage Completed2024-03-11In 2nd Scientific triage2024-02-29Review pending2024-02-29Evaluation requests sent to reviewers2024-02-28Scientific triage completed2024-02-28In scientific triage2024-02-28Manuscript accepted for processing2024-02-28Plagiarism check (submission) 1 ready2024-02-28Sent for anti-plagiarism verification2024-02-28Submissions Approved2024-02-27Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Mar 14 01:54:59 CST 2024, time=2024-03-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2192320, encodeId=a44621923203b, content=投稿命中率:95.0<br>偏重的研究方向:临床研究<br>经验分享:2023-10-25 Paid 2023-10-24 Accepted - invoice issued 2023-10-24 1st Post-Rev plagiarism check ready 2023-10-24 Sent for 1st Post-Rev antiplagiarism check 2023-10-24 Ready for Post-Rev antiplagiarism check 2023-10-24 Awaiting decision 2023-10-23 Review 2 pending 2023-10-23 Review 2 requests sent to reviewers 2023-10-21 After authors corrections 2023-10-09 Sent to author(s) for corrections (2 weeks) 2023-10-09 Reconsider after revision 2023-10-09 Awaiting decision 2023-10-09 2nd Scientific Triage Completed 2023-10-09 In 2nd Scientific triage 2023-10-06 Review pending 2023-10-03 Evaluation requests sent to reviewers 2023-09-23 Review pending 2023-08-31 Evaluation requests sent to reviewers 2023-08-29 Scientific triage completed 2023-08-29 In scientific triage 2023-08-29 Manuscript accepted for processing 2023-08-28 Plagiarism check (submission) 1 ready 2023-08-28 Sent for anti-plagiarism verification 2023-08-28 Submissions Approved 2023-08-28 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Sun Mar 10 00:10:47 CST 2024, time=2024-03-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190508, encodeId=970e219050833, content=在线等,急,请问让转投的Clinical Practice Review and Meta-Analysis这是本什么期刊?pubmed和Web of science都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Fri Mar 01 23:06:35 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2170547, encodeId=f97c21e054770, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综合<br>经验分享:从投到接收不到2个月,总的来说挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Nov 23 17:12:17 CST 2023, time=2023-11-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189743, encodeId=19892189e4301, content=审稿速度:6.0<br>经验分享:2024-02-25<br>Rejected - suggested journal transfer<br>Note: suggested_to Clinical Practice Review and Meta-Analysis<br>2024-01-15<br>Awaiting decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=大星猩, createdTime=Tue Feb 27 20:38:13 CST 2024, time=2024-02-27, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2189494, encodeId=5e8d21894944c, content=它让我转投Clinical Practice Review and Meta-Analysis,我搜都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Mon Feb 26 18:11:00 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189661, encodeId=53cc21896616d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:返修后杂志说crossed out text should be removed, blinded files should be uploaded, same applies to the response letter.到底是啥意思啊?有没有大佬知道的啊,着急死了。上传网页之前上传的文件是删不掉的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14388513788, createdName=ms4000000240525001, createdTime=Tue Feb 27 14:04:42 CST 2024, time=2024-02-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=573054, encodeId=d3855e305470, content=2019-06-27 - Sent to author for corrections (post-review verification) <br> Note: Your anti-plagiarism report is ready. Your manuscript has shown some degree of similarity to previously published material. Please reduce the similarity and rewrite your text where indicated. Be sure that all source material is properly cited and listed in the bibliography. You may upload your revised manuscript when ready. You will find the report in "Antiplagiarism Report" Tab in your Authors Account. <br> 2019-06-27 - After 1st post-review antiplagiarism verification <br> 2019-06-27 - Sent for 1st post-review antiplagiarism verification <br> 2019-06-27 - Ready for post-review antiplagiarism verification <br> 2019-06-27 - Awaiting decision <br> 2019-05-31 - Review 2 pending <br> 2019-05-31 - Review 2 requests sent to reviewers <br> 2019-05-08 - After authors corrections <br> 2019-05-01 - Sent to author for corrections (3 weeks) <br> 2019-05-01 - Reconsider after revision <br> 2019-04-30 - Awaiting decision <br> 2019-04-30 - 2nd Scientific Triage Completed <br> 2019-04-30 - In 2nd Scientific triage <br> 2019-04-18 - Review pending <br> 2019-04-18 - Evaluation requests sent to reviewers <br> 2019-04-17 - Unlocked <br> Note: Author uploaded new file. <br> 2019-04-16 - On hold <br> Note: Please provide us with legends for tables. Also, the entire file, containing all figures and tables, but without information about authors, should be uploaded for the review process. <br> 2019-04-15 - After scientific triage <br> 2019-04-14 - In scientific triage <br> 2019-04-14 - Manuscript accepted for processing <br> 2019-04-12 - Manuscript CrossChecked <br> 2019-04-12 - Sent for Plagiarism CrossCheck <br> 2019-04-12 - Submission Approved <br> 2019-04-12 - Incomplete, correction file uploaded <br> 2019-04-12 - Incomplete, waiting for authors reply <br> Note: The details in the message <br> 2019-04-12 - Incomplete, correction file uploaded <br> 2019-04-11 - Incomplete, waiting for authors reply <br> Note: The details in the message <br> 2019-04-11 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BSVB1WwY0QcChXdZibhTw8u2dzBZ0WtAodehibxMzLASJ1QbQd7oS4r1jvLfn5Eic4ID4qAkQTj55EmbFOHhJZ1rQ/132, createdBy=3bf32416063, createdName=912391303_75271680, createdTime=Fri Jun 28 10:47:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588261, encodeId=8b645882610c, content=您最后文章怎么样了?我也是这个状态<span class="quote">李医生 2020-02-24 00:00:00 发表:<br>你好,请问一下我已经到第三个黑框框了,上面显示 in 2nd scientific traige, review pending已经过去了,这代表什么意思,如果可以的话麻烦您能写一下您在投稿到接受之间的具体流程</span>, beContent=李医生 2020-02-24 00:00:00 发表: 你好,请问一下我已经到第三个黑框框了,上面显示 in 2nd scientific traige, review pending已经过去了,这代表什么意思,如果可以的话麻烦您能写一下您在投稿到接受之间的具体流程, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/E8F0816F065B9BD94C3C0E9796895C76/100, createdBy=c5142399843, createdName=CR7, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170968, encodeId=7ee421e0968b0, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:实在太难投了,根本没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bd8583610, createdName=ms8000002106570968, createdTime=Sat Nov 25 21:10:05 CST 2023, time=2023-11-25, status=1, ipAttribution=湖北省)]
    2020-04-06 CR7

    您最后文章怎么样了?我也是这个状态李医生 2020-02-24 00:00:00 发表:
    你好,请问一下我已经到第三个黑框框了,上面显示 in 2nd scientific traige, review pending已经过去了,这代表什么意思,如果可以的话麻烦您能写一下您在投稿到接受之间的具体流程

    李医生 2020-02-24 00:00:00 发表: 你好,请问一下我已经到第三个黑框框了,上面显示 in 2nd scientific traige, review pending已经过去了,这代表什么意思,如果可以的话麻烦您能写一下您在投稿到接受之间的具体流程

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2193071, encodeId=8f9921930e1ca, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:临床研究;科研<br>经验分享:2024-03-12Rejected2024-03-12Review - rejected2024-03-11Awaiting decision2024-03-112nd Scientific Triage Completed2024-03-11In 2nd Scientific triage2024-02-29Review pending2024-02-29Evaluation requests sent to reviewers2024-02-28Scientific triage completed2024-02-28In scientific triage2024-02-28Manuscript accepted for processing2024-02-28Plagiarism check (submission) 1 ready2024-02-28Sent for anti-plagiarism verification2024-02-28Submissions Approved2024-02-27Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Mar 14 01:54:59 CST 2024, time=2024-03-14, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2192320, encodeId=a44621923203b, content=投稿命中率:95.0<br>偏重的研究方向:临床研究<br>经验分享:2023-10-25 Paid 2023-10-24 Accepted - invoice issued 2023-10-24 1st Post-Rev plagiarism check ready 2023-10-24 Sent for 1st Post-Rev antiplagiarism check 2023-10-24 Ready for Post-Rev antiplagiarism check 2023-10-24 Awaiting decision 2023-10-23 Review 2 pending 2023-10-23 Review 2 requests sent to reviewers 2023-10-21 After authors corrections 2023-10-09 Sent to author(s) for corrections (2 weeks) 2023-10-09 Reconsider after revision 2023-10-09 Awaiting decision 2023-10-09 2nd Scientific Triage Completed 2023-10-09 In 2nd Scientific triage 2023-10-06 Review pending 2023-10-03 Evaluation requests sent to reviewers 2023-09-23 Review pending 2023-08-31 Evaluation requests sent to reviewers 2023-08-29 Scientific triage completed 2023-08-29 In scientific triage 2023-08-29 Manuscript accepted for processing 2023-08-28 Plagiarism check (submission) 1 ready 2023-08-28 Sent for anti-plagiarism verification 2023-08-28 Submissions Approved 2023-08-28 Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Sun Mar 10 00:10:47 CST 2024, time=2024-03-10, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2190508, encodeId=970e219050833, content=在线等,急,请问让转投的Clinical Practice Review and Meta-Analysis这是本什么期刊?pubmed和Web of science都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Fri Mar 01 23:06:35 CST 2024, time=2024-03-01, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2170547, encodeId=f97c21e054770, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:综合<br>经验分享:从投到接收不到2个月,总的来说挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c058351980, createdName=ms5000000983971375, createdTime=Thu Nov 23 17:12:17 CST 2023, time=2023-11-23, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189743, encodeId=19892189e4301, content=审稿速度:6.0<br>经验分享:2024-02-25<br>Rejected - suggested journal transfer<br>Note: suggested_to Clinical Practice Review and Meta-Analysis<br>2024-01-15<br>Awaiting decision, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa805698340, createdName=大星猩, createdTime=Tue Feb 27 20:38:13 CST 2024, time=2024-02-27, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2189494, encodeId=5e8d21894944c, content=它让我转投Clinical Practice Review and Meta-Analysis,我搜都搜不到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0afd5193394, createdName=Unparalled, createdTime=Mon Feb 26 18:11:00 CST 2024, time=2024-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2189661, encodeId=53cc21896616d, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:返修后杂志说crossed out text should be removed, blinded files should be uploaded, same applies to the response letter.到底是啥意思啊?有没有大佬知道的啊,着急死了。上传网页之前上传的文件是删不掉的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14388513788, createdName=ms4000000240525001, createdTime=Tue Feb 27 14:04:42 CST 2024, time=2024-02-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=573054, encodeId=d3855e305470, content=2019-06-27 - Sent to author for corrections (post-review verification) <br> Note: Your anti-plagiarism report is ready. Your manuscript has shown some degree of similarity to previously published material. Please reduce the similarity and rewrite your text where indicated. Be sure that all source material is properly cited and listed in the bibliography. You may upload your revised manuscript when ready. You will find the report in "Antiplagiarism Report" Tab in your Authors Account. <br> 2019-06-27 - After 1st post-review antiplagiarism verification <br> 2019-06-27 - Sent for 1st post-review antiplagiarism verification <br> 2019-06-27 - Ready for post-review antiplagiarism verification <br> 2019-06-27 - Awaiting decision <br> 2019-05-31 - Review 2 pending <br> 2019-05-31 - Review 2 requests sent to reviewers <br> 2019-05-08 - After authors corrections <br> 2019-05-01 - Sent to author for corrections (3 weeks) <br> 2019-05-01 - Reconsider after revision <br> 2019-04-30 - Awaiting decision <br> 2019-04-30 - 2nd Scientific Triage Completed <br> 2019-04-30 - In 2nd Scientific triage <br> 2019-04-18 - Review pending <br> 2019-04-18 - Evaluation requests sent to reviewers <br> 2019-04-17 - Unlocked <br> Note: Author uploaded new file. <br> 2019-04-16 - On hold <br> Note: Please provide us with legends for tables. Also, the entire file, containing all figures and tables, but without information about authors, should be uploaded for the review process. <br> 2019-04-15 - After scientific triage <br> 2019-04-14 - In scientific triage <br> 2019-04-14 - Manuscript accepted for processing <br> 2019-04-12 - Manuscript CrossChecked <br> 2019-04-12 - Sent for Plagiarism CrossCheck <br> 2019-04-12 - Submission Approved <br> 2019-04-12 - Incomplete, correction file uploaded <br> 2019-04-12 - Incomplete, waiting for authors reply <br> Note: The details in the message <br> 2019-04-12 - Incomplete, correction file uploaded <br> 2019-04-11 - Incomplete, waiting for authors reply <br> Note: The details in the message <br> 2019-04-11 - Submission Received, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BSVB1WwY0QcChXdZibhTw8u2dzBZ0WtAodehibxMzLASJ1QbQd7oS4r1jvLfn5Eic4ID4qAkQTj55EmbFOHhJZ1rQ/132, createdBy=3bf32416063, createdName=912391303_75271680, createdTime=Fri Jun 28 10:47:00 CST 2019, time=2019-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588261, encodeId=8b645882610c, content=您最后文章怎么样了?我也是这个状态<span class="quote">李医生 2020-02-24 00:00:00 发表:<br>你好,请问一下我已经到第三个黑框框了,上面显示 in 2nd scientific traige, review pending已经过去了,这代表什么意思,如果可以的话麻烦您能写一下您在投稿到接受之间的具体流程</span>, beContent=李医生 2020-02-24 00:00:00 发表: 你好,请问一下我已经到第三个黑框框了,上面显示 in 2nd scientific traige, review pending已经过去了,这代表什么意思,如果可以的话麻烦您能写一下您在投稿到接受之间的具体流程, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/E8F0816F065B9BD94C3C0E9796895C76/100, createdBy=c5142399843, createdName=CR7, createdTime=Mon Apr 06 00:00:00 CST 2020, time=2020-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2170968, encodeId=7ee421e0968b0, content=审稿速度:24.0 | 投稿命中率:5.0<br>经验分享:实在太难投了,根本没有审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d5bd8583610, createdName=ms8000002106570968, createdTime=Sat Nov 25 21:10:05 CST 2023, time=2023-11-25, status=1, ipAttribution=湖北省)]
    2023-11-25 ms8000002106570968 来自湖北省

    审稿速度:24.0 | 投稿命中率:5.0
    经验分享:实在太难投了,根本没有审稿人

    2

    展开2条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分